共 50 条
- [31] Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitorsINVESTIGATIONAL NEW DRUGS, 2020, 38 (03) : 885 - 893Ono, Taihei论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan论文数: 引用数: h-index:机构:Kurahayashi, Shintaro论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, JapanOkuma, Yuriko论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, JapanSugimoto, Ai论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, JapanKusuhara, Seiichiro论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, JapanOzawa, Takahiro论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan论文数: 引用数: h-index:机构:Sasaki, Jiichiro论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Res & Dev Ctr New Med Frontiers, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, JapanMitsufuji, Hisashi论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Nursing, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520329, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, JapanYokoba, Masanori论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, JapanKubota, Masaru论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, JapanKatagiri, Masato论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, JapanNaoki, Katsuhiko论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan Kitasato Univ, Dept Resp Med, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan
- [32] Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancerBRITISH JOURNAL OF CANCER, 2014, 111 (11) : 2203 - 2204Choughule, A.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaSharma, R.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaTrivedi, V.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaThavamani, A.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaNoronha, V.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaJoshi, A.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaDesai, S.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Pathol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaChandrani, P.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaSundaram, P.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaUtture, S.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaJambhekar, N.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Pathol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaGupta, S.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaAich, J.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaPrabhash, K.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, IndiaDutt, A.论文数: 0 引用数: 0 h-index: 0机构: Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Bombay 400012, Maharashtra, India
- [33] Spectrum of Resistance Mechanisms to First, Second and Third Generation Tyrosine Kinase Inhibitors in EGFR Mutant NSCLC PatientsJOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1106 - S1107Suryavanshi, M.论文数: 0 引用数: 0 h-index: 0机构: Rajiv Gandhi Canc Inst & Res Ctr, Mol Diagnost, Delhi, India Rajiv Gandhi Canc Inst & Res Ctr, Mol Diagnost, Delhi, IndiaMattoo, S.论文数: 0 引用数: 0 h-index: 0机构: Rajiv Gandhi Canc Inst & Res Ctr, Mol Diagnost, Delhi, India Rajiv Gandhi Canc Inst & Res Ctr, Mol Diagnost, Delhi, IndiaDhandha, S.论文数: 0 引用数: 0 h-index: 0机构: Rajiv Gandhi Canc Inst & Res Ctr, Mol Diagnost, Delhi, India Rajiv Gandhi Canc Inst & Res Ctr, Mol Diagnost, Delhi, IndiaMehta, A.论文数: 0 引用数: 0 h-index: 0机构: Rajiv Gandhi Canc Inst & Res Ctr, Mol Diagnost, Delhi, India Rajiv Gandhi Canc Inst & Res Ctr, Mol Diagnost, Delhi, IndiaBatra, U.论文数: 0 引用数: 0 h-index: 0机构: Rajiv Gandhi Canc Inst & Res Ctr, Med Oncol, Delhi, India Rajiv Gandhi Canc Inst & Res Ctr, Mol Diagnost, Delhi, India
- [34] Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitorsInvestigational New Drugs, 2020, 38 : 885 - 893Taihei Ono论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineSatoshi Igawa论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineShintaro Kurahayashi论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineYuriko Okuma论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineAi Sugimoto论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineSeiichiro Kusuhara论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineTakahiro Ozawa论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineTomoya Fukui论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineJiichiro Sasaki论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineHisashi Mitsufuji论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineMasanori Yokoba论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineMasaru Kubota论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineMasato Katagiri论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory MedicineKatsuhiko Naoki论文数: 0 引用数: 0 h-index: 0机构: Kitasato University School of Medicine,Department of Respiratory Medicine
- [35] EGFR-Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase InhibitorsJOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 585 - 590Barnet, Megan B.论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, AustraliaO'Toole, Sandra论文数: 0 引用数: 0 h-index: 0机构: Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Camperdown, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, AustraliaHorvath, Lisa G.论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, AustraliaSelinger, Christina论文数: 0 引用数: 0 h-index: 0机构: Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Camperdown, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, AustraliaYu, Bing论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Royal Prince Alfred Hosp, Dept Med Genom, Camperdown, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, AustraliaNg, Chiu Chin论文数: 0 引用数: 0 h-index: 0机构: Royal Prince Alfred Hosp, Dept Med Genom, Camperdown, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, AustraliaBoyer, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, AustraliaCooper, Wendy A.论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Camperdown, NSW, Australia Univ Western Sydney, Sch Med, Richmond, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, AustraliaKao, Steven论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
- [36] Impact of Neutrophil-to-Lymphocyte Ratio in Patients with EGFR-Mutant NSCLC Treated with Tyrosine Kinase InhibitorsJOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S610 - S610Ono, T.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan论文数: 引用数: h-index:机构:Yamada, K.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanKameda, A.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanOguri, A.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanYamamoto, H.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanManabe, H.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanOzawa, T.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanKusuhara, S.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanKasajima, M.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanKakegawa, M.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanOtani, S.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan论文数: 引用数: h-index:机构:Sasaki, J.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, JapanNaoki, K.论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan
- [37] Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancerBritish Journal of Cancer, 2014, 111 : 2203 - 2204A Choughule论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyR Sharma论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyV Trivedi论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyA Thavamani论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyV Noronha论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyA Joshi论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyS Desai论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyP Chandrani论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyP Sundaram论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyS Utture论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyN Jambhekar论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyS Gupta论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyJ Aich论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyK Prabhash论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical OncologyA Dutt论文数: 0 引用数: 0 h-index: 0机构: Tata Memorial Hospital,Department of Medical Oncology
- [38] Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC)ONCOTARGET, 2017, 8 (08) : 13304 - 13311Zhu, Qianqian论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R ChinaSun, Yanan论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R ChinaCui, Yingying论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R ChinaYe, Ke论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R ChinaYang, Chengliang论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R ChinaYang, Daoke论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R ChinaMa, Jie论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R ChinaLiu, Xiao论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R ChinaYu, Jinming论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, Jinan 250117, Shandong, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R ChinaGe, Hong论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou 450000, Henan Province, Peoples R China
- [39] Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesBMC Cancer, 18Wan-Ling Tan论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical OncologyQuan Sing Ng论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical OncologyCindy Lim论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical OncologyEng Huat Tan论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical OncologyChee Keong Toh论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical OncologyMei-Kim Ang论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical OncologyRavindran Kanesvaran论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical OncologyAmit Jain论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical OncologyDaniel S. W. Tan论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical OncologyDarren Wan-Teck Lim论文数: 0 引用数: 0 h-index: 0机构: National Cancer Centre Singapore,Division of Medical Oncology
- [40] The differential prognostic implications of PD-L1 expression in the outcomes of Filipinos with EGFR-mutant NSCLC treated with tyrosine kinase inhibitorsTRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (09) : 1896 - +Luna, Herdee Gloriane C.论文数: 0 引用数: 0 h-index: 0机构: Lung Ctr Philippines, Quezon Ave, Quezon City 1101, Philippines Natl Kidney & Transplant Inst, Quezon City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesImasa, Marcelo Severino论文数: 0 引用数: 0 h-index: 0机构: Lung Ctr Philippines, Quezon Ave, Quezon City 1101, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesJuat, Necy论文数: 0 引用数: 0 h-index: 0机构: Natl Kidney & Transplant Inst, Quezon City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesHernandez, Katherine, V论文数: 0 引用数: 0 h-index: 0机构: East Ave Med Ctr, Quezon City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesSayo, Treah May论文数: 0 引用数: 0 h-index: 0机构: Lung Ctr Philippines, Quezon Ave, Quezon City 1101, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesCristal-Luna, Gloria论文数: 0 引用数: 0 h-index: 0机构: Natl Kidney & Transplant Inst, Quezon City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesAsur-Galang, Sheena Marie论文数: 0 引用数: 0 h-index: 0机构: Philippine Council Hlth Res & Dev, Dept Sci & Technol, Clin Prote Canc Initiat, Taguig City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesBellengan, Mirasol论文数: 0 引用数: 0 h-index: 0机构: Philippine Council Hlth Res & Dev, Dept Sci & Technol, Clin Prote Canc Initiat, Taguig City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesDuga, Kent John论文数: 0 引用数: 0 h-index: 0机构: Philippine Council Hlth Res & Dev, Dept Sci & Technol, Clin Prote Canc Initiat, Taguig City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesBuenaobra, Bien Brian论文数: 0 引用数: 0 h-index: 0机构: Philippine Council Hlth Res & Dev, Dept Sci & Technol, Clin Prote Canc Initiat, Taguig City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesDe los Santos, Marvin I.论文数: 0 引用数: 0 h-index: 0机构: Philippine Council Hlth Res & Dev, Dept Sci & Technol, Clin Prote Canc Initiat, Taguig City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesMedina, Daniel论文数: 0 引用数: 0 h-index: 0机构: Philippine Council Hlth Res & Dev, Dept Sci & Technol, Clin Prote Canc Initiat, Taguig City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesSamo, Jamirah论文数: 0 引用数: 0 h-index: 0机构: Philippine Council Hlth Res & Dev, Dept Sci & Technol, Clin Prote Canc Initiat, Taguig City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, PhilippinesLiteral, Venus Minerva论文数: 0 引用数: 0 h-index: 0机构: Philippine Council Hlth Res & Dev, Dept Sci & Technol, Clin Prote Canc Initiat, Taguig City, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, Philippines论文数: 引用数: h-index:机构:Sy-Naval, Sullian论文数: 0 引用数: 0 h-index: 0机构: Lung Ctr Philippines, Quezon Ave, Quezon City 1101, Philippines Lung Ctr Philippines, Quezon Ave, Quezon City 1101, Philippines